secwatch / observer
8-K filed November 7, 2025, 6:59 PM ET ticker BKYI CIK 0001019034
regulatory confidence high sentiment negative materiality 0.55

BIO KEY INTERNATIONAL INC (BKYI): Nasdaq/NYSE listing notice — BIO-key receives Nasdaq extension to May 2026 to regain $1 bid price compliance

BIO KEY INTERNATIONAL INC

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BIO KEY INTERNATIONAL INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange
nasdaq
Notice
noncompliance notice
Deficiency
minimum bid price
Rules
5550(a)(2)
Exact text from the filing
November 6, 2025, the Company received a letter from Nasdaq (the “ Letter ”) stating that although the Company had not regained compliance with the Bid Price Rule, Nasdaq determined that the Company is eligible for an additional 180-day period, or until May 4, 2026, to regain compliance with the Bid Price Rule. In the Letter, Nasdaq stated that its determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the minimu
View on SEC.gov

Browse all listing & compliance notices →

BIO KEY INTERNATIONAL INC filing history →

Source: SEC EDGAR
accession 0001437749-25-033877
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.